FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...

From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing ...

The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...

Last week, Zydus Lifesciences confirmed the receipt of an FDA warning letter at its Waghodia plant in Gujarat, India, marking ...

A team comprising lead experts from WHO's headquarters in Geneva, India office, and drug regulators from other nations ...

The other highlight of the Modi-Biden meeting was India’s accession to the Clean Economy and Fair Economy agreements of the ...

Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% ...

Indian Patent Office to hear objections against Gilead's Lenacapavir patent claims, crucial for affordable HIV treatment ...

An Israeli-Indian treatment for knee pain caused by osteoarthritis has received Fast Track designation by the US Food and ...

OrthoFX™, a leading innovator in orthodontic solutions, proudly announces the official launch of its advanced NiTime™ Clear ...

Kolkata: Calcutta High Court on Thursday directed the additional solicitor-general to take instructions from the Centre about ways to import a particu.

India. And when confronted by the FDA inspectors, the plant management acknowledged the papers should not have been destroyed. In describing the episode, the FDA inspectors noted that the quality ...